Gilead Sciences Inc (NASDAQ:GILD)

67.10
Delayed Data
As of 4:00pm ET
 +0.74 / +1.12%
Today’s Change
60.32
Today|||52-Week Range
79.61
+7.27%
Year-to-Date
GILD Regular Dividend: GILD began trading ex-dividend on 06/13/19. A $0.63 dividend will be paid to shareholders of record as of 06/14/19.
5 Undervalued Stocks Growing Earnings
3:23pm / GuruFocus NewsGURU - Paid Partner Content
5 Companies Raising Earnings
Jun 13 / GuruFocus NewsGURU - Paid Partner Content
AstraZeneca Gives Detailed Data From Calquence Leukemia Study
10:33am / Zacks.comZAK - Paid Partner Content
Galapagos Ends Enrollment in Osteoarthritis Study Before Time
Jun 12 / Zacks.comZAK - Paid Partner Content
Better Buy: Aurora Cannabis vs. Gilead Sciences
Jun 16 / MotleyFool.comFOO - Paid Partner Content
CymaBay Down on Dismal Interim Data From Mid-Stage NASH Study
Jun 12 / Zacks.comZAK - Paid Partner Content
GILD vs. ILMN: Which Stock Is the Better Value Option?
Jun 14 / Zacks.comZAK - Paid Partner Content
Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year?
Jun 12 / Zacks.comZAK - Paid Partner Content
3 Top Dividend Stocks to Buy in June
Jun 14 / MotleyFool.comFOO - Paid Partner Content
Is the Newest Gene Editing Stock a Buy?
Jun 11 / MotleyFool.comFOO - Paid Partner Content

Today’s Trading

Previous close66.36
Today’s open66.47
Day’s range66.07 - 67.45
Volume4,781,426
Average volume (3 months)6,839,965
Market cap$84.4B
Data as of 4:00pm ET, 06/17/2019

Growth & Valuation

Earnings growth (last year)+18.72%
Earnings growth (this year)+2.88%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-15.00%
P/E ratio14.8
Price/Sales3.68
Price/Book3.98

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+2.31+1.31%
ILMNIllumina Inc+7.11+2.07%
BIIBBiogen+4.11+1.81%
EXASExact Sciences Corp+2.13+1.94%
Data as of 4:15pm ET, 06/17/2019

Financials

Next reporting dateJuly 24, 2019
EPS forecast (this quarter)$1.71
Annual revenue (last year)$22.2B
Annual profit (last year)$5.5B
Net profit margin24.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Daniel O'Day
CFO, Chief Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts